APOE and Alzheimer disease: Together, specific molecules of ApoE ε4 in AD and VEGF (VEGFδ/δ mice) in ALS support the idea that age-related decline in vascular healthiness increases the risk of AD and that of ALS, respectively [2,36,77,78].